TAR syndrome, short for thrombocytopenia-absent radius syndrome, is a rare genetic condition defined by two core features: a shortage of blood-clotting cells (platelets) and the bilateral absence of the radius bone in both forearms. It occurs in roughly 0.42 cases per 100,000 live births and follows an autosomal recessive inheritance pattern tied to mutations in a gene called RBM8A.1PubMed Central. Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia Despite the severity of its name, the blood problem tends to improve significantly during childhood, and many people with TAR syndrome go on to live functional lives with appropriate support.
What Happens in the Blood
The thrombocytopenia in TAR syndrome is not a typical low platelet count. It stems from a fundamental problem with the bone marrow cells that are supposed to produce platelets, called megakaryocytes. Research on bone marrow samples from affected individuals has found that megakaryocyte precursors are either absent or stuck at an early stage of development, meaning they never mature enough to release platelets into the bloodstream.2PubMed. Defective megakaryocytopoiesis in the syndrome of thrombocytopenia with absent radii Further studies suggest this may be driven by a reduced response to thrombopoietin, the hormone that signals megakaryocytes to grow and divide.3PubMed. Thrombocytopenia with absent radii (TAR) syndrome: from hemopoietic progenitor to mesenchymal stromal cell disease?
In practical terms, the platelet shortage is at its worst during the first few weeks to months of life, when counts can drop low enough to cause dangerous bleeding episodes. Intracranial hemorrhage during this early window is the most serious risk and is the leading cause of death in affected infants. The encouraging news is that platelet counts tend to climb on their own during infancy and typically reach near-normal levels by one to two years of age.4PubMed Central. Thrombocytopenia with Absent Radii (TAR) Syndrome Without Significant Thrombocytopenia The thrombocytopenia generally continues to improve through childhood, and many older children and adults with TAR syndrome have platelet counts that, while sometimes still on the low side, rarely cause spontaneous bleeding.5PubMed. Thrombocytopenia-absent radius syndrome
That said, platelet counts can temporarily dip during illnesses, surgeries, or other physiological stresses even later in life, so awareness of the condition remains relevant even after the worst period has passed. Platelet transfusions are the mainstay of managing acute bleeding episodes in infancy. During the critical early months, parents are typically counseled to watch for signs of bruising, petechiae (tiny pinpoint red spots on the skin), and any indication of internal bleeding.
The Skeletal Side
The “absent radius” in the name refers to the complete absence of the radius, one of the two bones in the forearm, on both sides. Because the radius is missing, the forearm and wrist develop abnormally. The ulna, the remaining forearm bone, is often shortened and bowed, and the hand tends to deviate to the radial (thumb) side of the wrist. This gives the forearms a distinctly curved appearance and limits the range of motion.
One feature that is critical for distinguishing TAR syndrome from other conditions with similar arm abnormalities: the thumbs are always present. Both thumbs are intact, though they may have limited function depending on the severity of the wrist and forearm deformity. This is a defining characteristic, because several other conditions that cause missing or malformed radii also cause absent or severely underdeveloped thumbs.6Consultant. Thrombocytopenia and Absent Radii Syndrome
Upper limb involvement is the hallmark, but it does not always stop at the forearm. Some individuals also have abnormalities in the humerus (upper arm bone) or the hands. In one case series, prenatal imaging revealed both radial agenesis and humeral underdevelopment.7PubMed Central. Prenatal diagnosis and post-mortem examination in a fetus with thrombocytopenia-absent radius (TAR) syndrome due to compound heterozygosity for a 1q21.1 microdeletion and a RBM8A hypomorphic allele: a case report Lower limb involvement is less common but does occur. In a series of five patients who underwent orthopedic reconstruction, one had severe internal rotation of the tibiae (shin bones) in addition to the upper limb defects.8PubMed Central. Reconstruction of limb deformities in patients with thrombocytopenia-absent radius syndrome Knee flexion contractures, where the knee cannot fully straighten, have also been reported.
The Genetics Behind It
TAR syndrome follows an autosomal recessive inheritance pattern, but it is not the simple “two copies of one bad gene” story that many recessive conditions follow. Instead, it typically results from compound heterozygosity involving two different kinds of genetic changes on chromosome 1q21.1, both affecting the RBM8A gene. One inherited copy carries a microdeletion that knocks out the gene entirely (a null allele), while the other carries a low-frequency, non-coding single nucleotide variant that weakens but does not eliminate gene function (a hypomorphic allele).9PubMed Central. Thrombocytopenia-Absent Radius Syndrome: Descriptions of Three New Cases and a Novel Splicing Variant in RBM8A That Expands the Spectrum of Null Alleles
This compound inheritance pattern explains something that puzzled geneticists for years. Many parents who carry the 1q21.1 microdeletion have no symptoms at all, and many people who carry the hypomorphic variant are also perfectly healthy. It is only when a child inherits both, one from each parent, that the RBM8A gene’s output drops below the threshold needed for normal development of megakaryocytes and radial bones.10PubMed. New insights into the genetic basis of TAR (thrombocytopenia-absent radii) syndrome The discovery of this mechanism was relatively recent and has been confirmed in prenatal cases where molecular testing identified one parent contributing the deletion and the other the non-coding variant.11PubMed. Prenatal detection of TAR syndrome in a fetus with compound inheritance of an RBM8A SNP and a 334‑kb deletion: a case report
RBM8A encodes a protein called Y14, which is part of the exon junction complex, a molecular machine involved in processing and quality-checking messenger RNA after genes are transcribed. When Y14 levels are too low, certain downstream processes in cell development go awry. Animal studies have helped flesh out this picture. In zebrafish, knocking out rbm8a leads to disorganized muscle fibers, reduced motor nerve outgrowth, and paralysis in embryos, suggesting that the protein plays a broad role in tissue development beyond just blood cells and bones.12PLOS Genetics. Zebrafish rbm8a and magoh mutants reveal EJC developmental functions and new 3′UTR intron-containing NMD targets Mouse studies have shown that reducing Rbm8a in the brain decreases the proliferation of certain neural progenitor cells, which may be connected to the developmental delays seen in some TAR patients.13PubMed Central. Full function of exon junction complex factor, Rbm8a, is critical for interneuron development
Beyond Blood and Bones
TAR syndrome is not exclusively a blood-and-bone condition. A range of additional features have been reported, though none appear in every patient. Congenital heart defects are among the more commonly noted associations. Ventricular septal defects (holes between the lower chambers of the heart) have been documented, and at least one case report describes successful surgical repair with cardiopulmonary bypass in a four-month-old with TAR syndrome, with minimal bleeding complications despite the underlying platelet disorder.14Journal of Surgery and Medicine. How to manage a congenital heart defect in a patient with thrombocytopenia-absent radius syndrome? Urinary tract anomalies and micrognathia (an unusually small jaw) have also been reported on prenatal imaging in affected fetuses.15PubMed Central. Prenatal diagnosis and post-mortem examination in a fetus with thrombocytopenia-absent radius (TAR) syndrome due to compound heterozygosity for a 1q21.1 microdeletion and a RBM8A hypomorphic allele: a case report
A less obvious association is cow’s milk protein intolerance. One well-documented case described an infant with TAR syndrome who developed severe diarrhea and dehydration that resolved when cow’s milk was removed from the diet and flared up again on three separate re-introductions. The gastrointestinal symptoms were accompanied by drops in platelet counts and rises in white blood cell counts and eosinophils, suggesting a connection between the milk exposure and the hematological instability.16PubMed Central. Cows’ milk allergy in the syndrome of thrombocytopenia with absent radius This link is not fully understood, but some clinicians factor it into dietary guidance for infants with TAR syndrome, particularly during the early months when platelet counts are most fragile. Avoiding potential triggers for hematological relapse can matter a great deal when platelet reserves are already dangerously thin.
How TAR Syndrome Is Told Apart from Similar Conditions
Absent or malformed radii are not unique to TAR syndrome. Several other conditions include radial ray defects as part of their presentation, and telling them apart is essential because they carry very different prognoses and treatment implications. In one review of 34 patients with radial ray defects, only four had TAR syndrome; the rest were diagnosed with conditions like Holt-Oram syndrome, Fanconi anemia, or VACTERL association.17PubMed. Radial ray defects and associated anomalies
The key distinguishing features work as a process of elimination:
- Thumbs present: In TAR syndrome, both thumbs are intact. Fanconi anemia, Holt-Oram syndrome, and VACTERL association often involve absent or severely underdeveloped thumbs.
- Thrombocytopenia required: A low platelet count is mandatory for a TAR diagnosis. Other radial ray conditions may affect the blood in different ways (Fanconi anemia involves progressive bone marrow failure and cancer predisposition) or not at all.
- No chromosomal breakage: Fanconi anemia is caused by defects in DNA repair and is identified by a characteristic chromosomal breakage test. TAR syndrome does not show this pattern.
- No cardiac defect as the central feature: Holt-Oram syndrome pairs upper limb malformations with congenital heart defects, particularly atrial septal defects. While heart defects can occur in TAR, they are not its defining feature.
Genetic testing has made these distinctions considerably more reliable. Confirming the compound heterozygosity of a 1q21.1 deletion plus an RBM8A non-coding variant effectively clinches the diagnosis.18Journal of Pediatric Res. Severe Extremity Anomaly and Neurodevelopmental Retardation in an Infant with TAR Syndrome and Differential Diagnosis in Radial Defects Prenatal diagnosis is also possible. When ultrasound reveals bilateral radial absence with preserved thumbs, array-based testing and sequencing of RBM8A can confirm the diagnosis before birth, allowing families and care teams to plan for the immediate postnatal period when the bleeding risk is highest.19PubMed. Prenatal detection of TAR syndrome in a fetus with compound inheritance of an RBM8A SNP and a 334‑kb deletion: a case report
Orthopedic Treatment and Functional Outcomes
Because the thrombocytopenia improves with age, the long-term challenge for many people with TAR syndrome shifts from bleeding risk to physical function. The absent radius causes the forearm to bow, the wrist to deviate, and grip strength and range of motion to suffer. Orthopedic reconstruction can meaningfully improve these problems, though it does not create a normal forearm from scratch.
Surgical approaches typically focus on straightening the ulna, realigning the wrist, and rebalancing the tendons and muscles around it so the hand sits in a more functional position. In a series of five patients who received these interventions, the wrist was stabilized and the forearm bow corrected. Patients regained the ability to perform most daily activities, though they retained some limitation in wrist extension and overall finger range of motion.20PubMed Central. Reconstruction of limb deformities in patients with thrombocytopenia-absent radius syndrome
Another group reported a two-stage approach: first correcting the forearm deformity, then addressing lower limb problems where present. Their measurements showed substantial improvement in the angle between the hand and forearm after surgery, from an average of about 83 degrees preoperatively to under 6 degrees immediately after the procedure. Some degree of deformity recurrence was seen during follow-up, but only one patient in the series required additional surgery for it.21PubMed Central. Two-stage treatment of extremity deformities associated with thrombocytopenia-absent radius syndrome The timing of these surgeries is important. The platelet count needs to be stable enough to safely undergo anesthesia and tolerate the bleeding associated with bone and soft tissue procedures, which usually means waiting until the thrombocytopenia has improved in later infancy or early childhood.
What Triggers Bleeding Episodes After Infancy
Even once platelet counts have risen to safer levels, people with TAR syndrome can experience temporary drops. Infections are a common trigger, particularly viral illnesses that stress the bone marrow. Surgery, as noted above, is another situation where platelet counts need monitoring. There have also been reports of gastrointestinal triggers, including the cow’s milk link described earlier.22PubMed Central. Cows’ milk allergy in the syndrome of thrombocytopenia with absent radius The practical upshot is that a person with TAR syndrome should have a hematologist involved in their care on an ongoing basis, even during periods when blood counts look reassuring. Preoperative platelet checks and having a transfusion plan ready remain standard practice before any invasive procedure throughout life.
Neurodevelopmental Considerations
Most discussions of TAR syndrome focus on the blood and skeletal features, but there is growing interest in whether RBM8A deficiency affects brain development. Some children with TAR syndrome experience developmental delays, and one case report specifically highlighted neurodevelopmental retardation as a component of the presentation.23Journal of Pediatric Res. Severe Extremity Anomaly and Neurodevelopmental Retardation in an Infant with TAR Syndrome and Differential Diagnosis in Radial Defects Laboratory work in mice has shown that reducing Rbm8a levels in brain tissue decreases the proliferation of progenitor cells in regions that give rise to certain types of neurons, and that deleting it from specific interneuron progenitors alters the distribution of those neurons in the brain.24PubMed Central. Full function of exon junction complex factor, Rbm8a, is critical for interneuron development
How directly these animal findings translate to cognitive outcomes in humans remains unclear. It is plausible that low Y14 levels during fetal brain development could affect neuron production, but many children with TAR syndrome develop typically. Severe intracranial hemorrhage during the neonatal period, when platelet counts are at their lowest, could also contribute to developmental problems independently of any direct genetic effect on the brain. Separating the contribution of bleeding events from a primary developmental effect of RBM8A deficiency is difficult, and no large-scale study has yet disentangled the two.
Thrombopoietin Receptor Agonists and Future Directions
Standard treatment for the thrombocytopenia in TAR syndrome is supportive: platelet transfusions when counts are dangerously low, avoidance of known triggers, and watchful waiting as the condition tends to improve with age. There is no drug that corrects the underlying megakaryocyte defect. However, a class of medications called thrombopoietin receptor agonists (TPO-RAs), which stimulate platelet production, has generated interest as a possible tool for managing inherited thrombocytopenias.
A review of the literature from 2010 through early 2021 identified 126 patients with various inherited thrombocytopenias who had been treated with TPO-RAs, mostly in clinical trials or case reports. The conditions treated were primarily Wiskott-Aldrich syndrome, MYH9-related disorder, and ANKRD26-related thrombocytopenia, and most patients received the drugs as short-term bridging therapy before surgery or stem cell transplantation rather than as long-term maintenance.25PubMed Central. Role of Thrombopoietin Receptor Agonists in Inherited Thrombocytopenia Because the thrombocytopenia in TAR syndrome appears to involve a reduced response to thrombopoietin at the progenitor cell level, it is not obvious that simply providing more of the signal would overcome the problem.26PubMed. Thrombocytopenia with absent radii (TAR) syndrome: from hemopoietic progenitor to mesenchymal stromal cell disease? Still, TPO-RAs could theoretically push the few responsive progenitors to produce more platelets, and the approach remains an area worth watching as more data accumulate from the broader inherited thrombocytopenia population.
Gene therapy, which has advanced rapidly for other genetic blood disorders, is a more speculative future possibility. Since TAR syndrome results from insufficient RBM8A gene output rather than a toxic gain-of-function mutation, restoring gene expression in megakaryocyte progenitors could in theory correct the platelet deficit. No gene therapy trials for TAR syndrome are currently underway, but the condition’s well-defined genetic mechanism makes it a plausible candidate as the technology matures. For now, the self-improving nature of the thrombocytopenia reduces the clinical urgency for such interventions compared with conditions where the blood counts worsen over time.